William DeMaio, Ph.D., has been named senior director of the drug metabolism and pharmacokinetics (DMPK) department at Ricerca Biosciences. Dr. DeMaio joins a team of bioanalytical and drug metabolism scientists that offers support for Ricerca’s discovery and preclinical development programs.

“Dr. DeMaio has an international reputation as one of the pharmaceutical industry’s best mass spectrometrists and metabolism scientists,” stated Dr. Michael Placke, senior vice president and general manager of Ricerca’s Concord, OH, drug development operations. “Bill has solved most challenges one is likely to encounter in characterizing drug product exposure and metabolizing identification in both non-clinical and clinical settings.”

Prior to joining the company, Dr. DeMaio was associate director of biotransformation at Wyeth Research in Collegeville, PA, where he was responsible for drug metabolite identification and metabolism characterization by mass spectrometry. Dr. DeMaio has expertise in chromatography, mass spectrometry, structural elucidation and drug development, as well as operating GLP-compliant bioanalytical and metabolism operations and training analysts in use of LC/MS equipment and data analysis.